TagipMet (sitagliptin + metformin): Uses, Dosage & Side Effects

What it's for (Indications)

Sitagliptin + Metformin is indicated for the treatment of type 2 diabetes mellitus.
It can be used as monotherapy for type 2 diabetes inadequately controlled by metformin, diet, and exercise.
It is also used as dual therapy along with metformin or a glitazone when patients respond inadequately to diet, exercise, and either metformin or a glitazone, or in combination with sulfonylureas in patients for whom metformin is contraindicated or who do not respond adequately to sulfonylureas alone.
Furthermore, it can be used as triple therapy with metformin and a sulfonylurea or glitazone for type 2 diabetes inadequately controlled by dual therapy, and with or without metformin in patients who respond inadequately to diet, exercise, and insulin.

Dosage Information

Type	Guideline
Standard	The medication, such as Sita-Met 50mg/500mg, should be taken exactly as prescribed by your doctor. It is important to adhere to your doctor's instructions and complete the full course to achieve the best results. Dose adjustment might be required for kidney patients.

Safety & Warnings

Common Side Effects

Possible side effects include upper respiratory infections, headache, abdominal pain, nausea, diarrhea, joint pain, dizziness, gastrointestinal disturbances, flatulence, swelling, and influenza-like symptoms.
More serious, though rare, adverse events can include pancreatitis (inflammation of the pancreas), severe allergic reactions (including Stevens-Johnson Syndrome and bullous pemphigoid), and hypoglycemia (low glucose levels).
Osteoarthritis (weak bones) has also been reported.

Serious Warnings

Black Box Warning: None
Patients with a history of pancreatitis, kidney issues/disease, heart failure, or gallstones should use this medication cautiously; it is crucial to inform your doctor about these conditions.
Sitagliptin should be used cautiously in nursing females, though it is strongly advised against use during breastfeeding.
Dose adjustment might be required for kidney patients.
Alcohol consumption should be avoided during treatment as it is considered unsafe.
This medicine might affect driving ability if blood sugar levels become too low; avoid driving until your glucose levels are controlled.
Inform your doctor about all current medications.
Do not discontinue this medicine without informing your doctor, do not share it, and do not double the dose as it may lead to severe hypoglycemia.
Consult your doctor immediately if symptoms of pancreatitis develop.
Stay hydrated and follow your doctor's dietary recommendations.

How it Works (Mechanism of Action)

This medication works to decrease blood glucose levels, ultimately reducing the probability of heart and kidney disease. A detailed specific mechanism of action is not provided in the available data.